LIFEVANTAGE CORP Repayments of Long-Term Debt
LIFEVANTAGE CORP (LFVN) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2022-06-30, per its 10-K filed 2022-08-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2022-08-23
- LIFEVANTAGE CORP repayments of long-term debt for the quarter ending 2021-06-30 was $0.00.
- LIFEVANTAGE CORP repayments of long-term debt for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- LIFEVANTAGE CORP repayments of long-term debt for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- LIFEVANTAGE CORP repayments of long-term debt for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- LIFEVANTAGE CORP repayments of long-term debt for fiscal 2022 was $0.00.
- LIFEVANTAGE CORP repayments of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- LIFEVANTAGE CORP repayments of long-term debt for fiscal 2020 was $1.50M, a 62.50% decline from fiscal 2019.
- LIFEVANTAGE CORP repayments of long-term debt for fiscal 2019 was $4.00M, a 100.00% increase from fiscal 2018.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 10-K · filed 2022-08-23 | |||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $0.00 derived: sum of 2 quarters · filed 2022-08-23 | $0.00 derived: sum of 3 quarters · filed 2022-08-23 | $0.00 10-K · filed 2022-08-23 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2021-04-29 | $0.00 10-Q · filed 2021-04-29 | $0.00 derived: sum of 4 quarters · filed 2022-08-23 |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-02 | $0.00 10-Q · filed 2021-02-02 | $0.00 derived: sum of 3 quarters · filed 2022-08-23 | $500.00K derived: sum of 4 quarters · filed 2022-08-23 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-08-23 | $500.00K derived: sum of 3 quarters · filed 2022-08-23 | $1.00M derived: sum of 4 quarters · filed 2022-08-23 |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $500.00K derived: sum of 2 quarters · filed 2022-08-23 | $1.00M derived: sum of 3 quarters · filed 2022-08-23 | $1.50M 10-K · filed 2022-08-23 |
| 2020-03-31 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-29 | $1.00M derived: sum of 2 quarters · filed 2021-04-29 | $1.50M 10-Q · filed 2021-04-29 | $2.00M derived: sum of 4 quarters · filed 2021-08-19 |
| 2019-12-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-02 | $1.00M 10-Q · filed 2021-02-02 | $1.50M derived: sum of 3 quarters · filed 2021-08-19 | $4.00M derived: sum of 4 quarters · filed 2021-08-19 |
| 2019-09-30 | $500.00K 10-Q · filed 2020-11-03 | $1.00M derived: sum of 2 quarters · filed 2021-08-19 | $3.50M derived: sum of 3 quarters · filed 2021-08-19 | $4.00M derived: sum of 4 quarters · filed 2021-08-19 |
| 2019-06-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-19 | $3.00M derived: sum of 2 quarters · filed 2021-08-19 | $3.50M derived: sum of 3 quarters · filed 2021-08-19 | $4.00M 10-K · filed 2021-08-19 |
| 2019-03-31 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-05 | $3.00M derived: sum of 2 quarters · filed 2020-05-05 | $3.50M 10-Q · filed 2020-05-05 | $4.00M derived: sum of 4 quarters · filed 2020-08-18 |
| 2018-12-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-28 | $1.00M 10-Q · filed 2020-01-28 | $1.50M derived: sum of 3 quarters · filed 2020-08-18 | $2.00M derived: sum of 4 quarters · filed 2020-08-18 |
| 2018-09-30 | $500.00K 10-Q · filed 2019-10-30 | $1.00M derived: sum of 2 quarters · filed 2020-08-18 | $1.50M derived: sum of 3 quarters · filed 2020-08-18 | $2.00M derived: sum of 4 quarters · filed 2020-08-18 |
| 2018-06-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-18 | $1.00M derived: sum of 2 quarters · filed 2020-08-18 | $1.50M derived: sum of 3 quarters · filed 2020-08-18 | $2.00M 10-K · filed 2020-08-18 |
| 2018-03-31 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-01 | $1.00M derived: sum of 2 quarters · filed 2019-05-01 | $1.50M 10-Q · filed 2019-05-01 | $2.00M derived: sum of 4 quarters · filed 2019-08-14 |
| 2017-12-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-04 | $1.00M 10-Q · filed 2019-02-04 | $1.50M derived: sum of 3 quarters · filed 2019-08-14 | $2.00M derived: sum of 4 quarters · filed 2019-08-14 |
| 2017-09-30 | $500.00K 10-Q · filed 2018-11-01 | $1.00M derived: sum of 2 quarters · filed 2019-08-14 | $1.50M derived: sum of 3 quarters · filed 2019-08-14 | $2.00M derived: sum of 4 quarters · filed 2019-08-14 |
| 2017-06-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-14 | $1.00M derived: sum of 2 quarters · filed 2019-08-14 | $1.50M derived: sum of 3 quarters · filed 2019-08-14 | $2.00M 10-K · filed 2019-08-14 |
| 2017-03-31 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $1.00M derived: sum of 2 quarters · filed 2018-05-09 | $1.50M 10-Q · filed 2018-05-09 | $2.00M derived: sum of 4 quarters · filed 2018-08-15 |
| 2016-12-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07 | $1.00M 10-Q · filed 2018-02-07 | $1.50M derived: sum of 3 quarters · filed 2018-08-15 | $16.31M derived: sum of 4 quarters · filed 2018-08-15 |
| 2016-09-30 | $500.00K 10-Q · filed 2017-11-08 | $1.00M derived: sum of 2 quarters · filed 2018-08-15 | $15.81M derived: sum of 3 quarters · filed 2018-08-15 | $19.51M derived: sum of 4 quarters · filed 2018-08-15 |
| 2016-06-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-15 | $15.31M derived: sum of 2 quarters · filed 2018-08-15 | $19.01M derived: sum of 3 quarters · filed 2018-08-15 | $22.13M 10-K · filed 2018-08-15 |
| 2016-03-31 | $14.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $18.51M derived: sum of 2 quarters · filed 2017-05-10 | $21.63M 10-Q · filed 2017-05-10 | $27.30M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-12-31 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $6.81M 10-Q · filed 2017-02-08 | $12.49M derived: sum of 3 quarters · filed 2017-09-07 | $13.66M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | $3.12M 10-Q · filed 2016-12-12 | $8.79M derived: sum of 2 quarters · filed 2017-09-07 | $9.97M derived: sum of 3 quarters · filed 2017-09-07 | $11.14M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-06-30 | $5.67M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-09-07 | $6.85M derived: sum of 2 quarters · filed 2017-09-07 | $8.03M derived: sum of 3 quarters · filed 2017-09-07 | $9.20M 10-K · filed 2017-09-07 |
| 2015-03-31 | $1.18M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2016-07-19 | $2.35M derived: sum of 2 quarters · filed 2016-07-19 | $3.52M 10-Q/A · filed 2016-07-19 | $18.52M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $2.35M 10-Q · filed 2016-02-09 | $17.35M derived: sum of 3 quarters · filed 2016-12-12 | $18.52M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | $1.18M 10-Q · filed 2015-11-04 | $16.18M derived: sum of 2 quarters · filed 2016-12-12 | $17.35M derived: sum of 3 quarters · filed 2016-12-12 | $17.35M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-06-30 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $16.18M derived: sum of 2 quarters · filed 2016-12-12 | $16.18M derived: sum of 3 quarters · filed 2016-12-12 | $16.18M 10-K · filed 2016-12-12 |
| 2014-03-31 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $1.18M derived: sum of 2 quarters · filed 2015-05-06 | $1.18M 10-Q · filed 2015-05-06 | $1.18M derived: sum of 4 quarters · filed 2015-09-01 |
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | $0.00 10-Q · filed 2015-02-04 | $0.00 derived: sum of 3 quarters · filed 2015-09-01 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-09-01 | ||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-01 | $0.00 10-K · filed 2015-09-01 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-06 | |||
| 2012-06-30 | $0.00 10-K · filed 2014-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |